Legislation

This ordinance allows certain existing medical cannabis dispensaries to switch to cannabis retail without needing to notify or seek approval from the neighborhood. It also confirms that this change aligns with environmental regulations and city planning policies.

Ordinance amending the Planning Code to exempt Grandfathered Medical Cannabis Dispensaries that convert to Cannabis Retail Uses from neighborhood notification and review requirements; affirming the Planning Department’s determination under the California Environmental Quality Act; making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1; and making public necessity, convenience, and welfare findings under Planning Code, Section 302.

The ordinance authorizes a $3,250,000 settlement for a lawsuit regarding alleged medical negligence against the City and County of San Francisco. It also includes a waiver of future wrongful death claims by certain individuals involved in the case.

Ordinance authorizing settlement of the lawsuit filed by David Joslyn against the City and County of San Francisco for $3,250,000; the lawsuit was filed on October 2, 2019, in San Francisco Superior Court, Case No. CGC-19-579230; entitled David Joslyn, et al. v. City and County of San Francisco, et al.; the lawsuit involves alleged personal injury from medical negligence; other material terms of the settlement are that Iris Solano, Frederick Stewart Joslyn and Iris Lorraine Solano waive any potential future claims for wrongful death.

The ordinance allows the Office of Economic and Workforce Development to set standards for cannabis-related training programs focused on social equity and business development. It also extends the temporary operating period for medical cannabis dispensaries awaiting permit approval from 120 to between 150 and 180 days, with new requirements related to hiring practices and labor agreements.

Ordinance amending the Police Code to clarify that the Office of Economic and Workforce Development (“OEWD”) may establish standards governing the certification of cannabis-related pre-apprenticeship programs that relate to social equity training, license incubation processes, underserved community outreach programs, and business plan development training; and amending the Health Code to extend from 120 days to between 150 and 180 days the period for which the Director of the Office of Cannabis (“OOC”) may grant temporary authorization to medical cannabis dispensaries (“MCDs”) to continue operating while they wait for the OOC to process their applications for cannabis business permits (“Temporary MCD Authorization”), and to add as prerequisites to Temporary MCD Authorization: that the MCD has not been found to have violated health and safety standards developed by the Director to protect the health and safety of employees, neighbors, and customers; that OEWD has not made a determination, or has determined that the MCD ensures that 35% of its new hires shall be registered apprentices enrolled in an approved apprenticeship program if feasible; and for any MCD with ten or more employees, that OEWD has not made a determination, or has determined that the MCD has entered into or made good faith efforts to enter into a Labor Peace Agreement or a collective bargaining agreement with a Bona Fide Labor Organization.

This resolution allows the California Statewide Communities Development Authority to issue up to $45 million in bonds to refinance seismic upgrades and other improvements at health care facilities operated by the Chinese Hospital Association. It is a financial measure aimed at enhancing safety and infrastructure in those facilities.

Resolution approving for purposes of Internal Revenue Code, Section 147(f), the Issuance and Sale of Limited Obligation Improvement Bonds by the California Statewide Communities Development Authority in an aggregate principal amount not to exceed $45,000,000 to refinance the acquisition, construction and installation of seismic strengthening improvements and other authorized improvements in certain health care facilities owned and operated by Chinese Hospital Association, a California nonprofit public benefit corporation.

This resolution approves a settlement where Medtronic will pay the City $800,000 and return a fleet of ventilators at their expense. The claim was related to an issue that did not go to court.

Resolution approving the settlement of the unlitigated claim filed by the City against Covidien Sales LLC, a Medtronic Company (Medtronic) for $800,000 including the return of a ventilator fleet at Medtronic’s expense.

This resolution approves an increase in funding for the San Francisco AIDS Foundation to provide HIV prevention services, specifically through syringe access and disposal, raising the total contract amount to over $42 million. The contract term remains unchanged, running from July 1, 2016, to June 30, 2026.

Resolution approving Amendment No. 3 to the agreement between the San Francisco AIDS Foundation and the Department of Public Health to provide HIV prevention services through City-wide syringe access and disposal services; to increase the contract amount by $6,507,312 for a total amount not to exceed $42,115,471 with no change to the contract term of July 1, 2016, through June 30, 2026, to commence upon Board approval.

This resolution allows the Department of Public Health to apply for over $5 million in federal funding to support HIV surveillance and prevention programs in San Francisco for the year 2022. It aims to continue efforts in managing and preventing HIV within the community.

Resolution authorizing the Department of Public Health to submit a one-year application for Calendar Year 2022 to continue to receive funding for the Integrated HIV Surveillance and Prevention Programs for Health Departments from the Centers of Disease Control and Prevention, requesting $5,008,377 in HIV prevention funding for San Francisco from January 1, 2022, through December 31, 2022.

This resolution allows the Office of Economic and Workforce Development to use a $500,000 grant to support an additional 100 workers in San Francisco who lost their jobs due to COVID-19. The funding comes from the North Valley Workforce Development Board and is intended to enhance the city's workforce development efforts until August 19, 2023.

Resolution retroactively authorizing the Office of Economic and Workforce Development to accept and expend a grant in the amount of $500,000 from the North Valley Workforce Development Board, a recipient of the grant award from United States Department of Labor for CAREER National Dislocated Worker Grant to expand San Francisco’s public workforce development system to respond to an additional 100 dislocated workers impacted by COVID-19 for the grant period of October 1, 2021, through August 19, 2023.

The ordinance updates zoning rules for massage establishments in San Francisco, including reclassifying sole practitioner massage services and aligning their regulations with health services. It also introduces restrictions on personal services at locations where massage establishments were closed due to violations and removes certain outdated provisions.

Ordinance amending the Planning Code to revise Massage Establishment zoning controls, including, among other things, to: 1) add Sole Practitioner Massage Establishments to the definition of Health Services in Articles 1 and 8 and remove it from the definition of Massage Establishments; 2) regulate Massage Establishments generally consistent with Health Services, with some exceptions; 3) eliminate the three-month period to establish abandonment of certain nonconforming Massage Establishment uses; 4) prohibit Personal Services uses for three years at any location where a Massage Establishment use was closed due to a violation of the Planning Code or Health Code; 5) eliminate the exception from the conditional use authorization requirement for massage uses accessory to a dwelling unit; 6) rename Medical Services to Health Services in Article 8 and make other conforming amendments; and 7) delete related provisions that have expired through the passage of time; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1, and public necessity, convenience, and general welfare findings pursuant to Planning Code, Section 302.

This resolution calls on the U.S. Department of Veterans Affairs and the San Francisco Fort Miley Department of Veteran Affairs to recognize and address the health care disparities faced by transgender veterans, particularly black transgender and repatriated veterans. It urges them to create strategies to improve access to essential benefits for these groups.

Resolution urging the United States Department of Veterans Affairs and the San Francisco Fort Miley Department of Veteran Affairs to acknowledge the disparities of physical and psychological health and medical care among transgender, black transgender, and repatriated veterans; and to develop transformative strategies for increasing access to these necessary veteran affairs benefits.

This resolution encourages bike and scooter share companies in San Francisco to improve rider compliance with existing rules and calls for the city’s transportation agency to create stricter permit conditions for future programs to enhance public safety, especially for vulnerable groups. It aims to ensure safer use of these shared transportation options for everyone.

Resolution urging permittees of San Francisco’s Bicycle Share and Powered Scooter Share Programs to implement measures to advance rider compliance with existing terms and conditions of San Francisco’s Bicycle Share and Powered Scooter Share Program requirements, and urging the San Francisco Municipal Transportation Agency and its Board of Directors to establish new permit terms and conditions for future permits that further serve the goal of ensuring the public health and safety of pedestrians, seniors, and people with disabilities.

This legislation calls for a hearing to address the staffing shortages at San Francisco General Hospital. It requests reports from the hospital and relevant city departments on the issue.

Hearing on the ongoing staffing shortages at San Francisco General Hospital; and requesting San Francisco General Hospital, the Department of Public Health, and Department of Human Resources to report.

The ordinance authorizes a partial settlement of a lawsuit against three major opioid distributors, aiming to secure between $27 million and $50 million in abatement funds over 18 years. This lawsuit alleges that these companies contributed to the opioid crisis in San Francisco by distributing excessive amounts of opioids while ignoring legal obligations to monitor and report suspicious orders.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws by distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

The ordinance authorizes a partial settlement of a lawsuit against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, for $6 million to $11 million over nine years due to their role in the opioid crisis. The lawsuit alleges that they created a public nuisance and violated laws through deceptive marketing and distribution of opioids in San Francisco.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over 9 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that Johnson and Johnson’s subsidiary, Janssen Pharmaceuticals, Inc., created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws through deceptive marketing of opioids, manufacturing and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and to report suspicious opioid orders as required by state and federal law.

This resolution approves an extension of a contract with HealthRIGHT 360 for financial services related to public health, increasing the total agreement amount to $46,766,160 and extending the contract term until June 30, 2023. It also allows the Department of Public Health to make necessary amendments to the contract without increasing the city's financial obligations.

Resolution retroactively approving Amendment No. 1 to the agreement between HealthRIGHT 360 and the Department of Public Health (DPH) for fiscal intermediary check-writing services, in an amount not to exceed $46,766,160; to extend the term by one year and eleven months, from July 31, 2021, for a total agreement term of January 1, 2021, through June 30, 2023; and to authorize DPH to enter into amendments or modifications to the contract, as defined herein, that do not increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.

This legislation calls for a hearing to discuss the interim use plan for 730 Stanyan Street. It requests presentations from the Mayor's Office of Housing and Community Development, the Department of Homelessness and Supportive Housing, and the Department of Public Health.

Hearing on the interim use plan for 730 Stanyan Street; and requesting the Mayor's Office of Housing and Community Development, Department of Homelessness and Supportive Housing, and Department of Public Health to present.

This hearing focuses on reviewing the Budget and Appropriations Committee's spending plan for 2021-2023, particularly for essential human services. It requests reports from several city departments, including Public Health and Homelessness, on their spending plans.

Hearing on the Budget and Appropriations Committee's 2021-2023 spending plan, specifically departmental spending plans for essential human services; and requesting the Department of Public Health, Department of Homelessness and Supportive Housing, Mayor's Office of Housing and Community Development, and the Office of Economic and Workforce Development to report.

This ordinance removes the Life Science and Medical Special Use District from the Planning Code and Zoning Map. It also confirms that the changes align with environmental regulations and the city's General Plan priorities.

Ordinance amending the Planning Code and Zoning Map to eliminate the Life Science and Medical Special Use District; affirming the Planning Department’s determination under the California Environmental Quality Act; making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1; and adopting findings of public necessity, convenience, and welfare under Planning Code, Section 302.

This ordinance allows the Department of Public Health to accept and use a $658,150 grant from the California Department of Public Health for a home visiting program, covering the period from July 1, 2021, to June 30, 2023. It also adds one full-time Public Health Nurse position funded by this grant.

Ordinance retroactively authorizing the Department of Public Health to accept and expend a grant in the amount of $658,150 from the California Department of Public Health for participation in a program, entitled “California Home Visiting State General Fund Expansion,” for the period of July 1, 2021, through June 30, 2023; and amending Ordinance No. 109-21 (Annual Salary Ordinance File No. 210644 for Fiscal Years 2021-2022 and 2022-2023) to provide for the addition of one grant-funded full-time position in Class 2830 Public Health Nurse (1.0 FTE).

This resolution allows the Department of Public Health to apply for continued funding under the Ryan White Act for HIV/AIDS emergency relief, requesting over $15.5 million for the San Francisco area for the upcoming year. It has been approved to support ongoing HIV/AIDS services in the community.

Resolution authorizing the Department of Public Health to submit an application to continue to receive funding for the Ryan White Act HIV/AIDS Emergency Relief Grant Program from the Health Resources Services Administration; and requesting $15,590,728 in HIV Emergency Relief Program funding for the San Francisco Eligible Metropolitan Area for the period of March 1, 2022, through February 28, 2023.

This ordinance allows the City Administrator to modify leases and forgive rent for nonresidential tenants who faced financial hardship during the COVID-19 pandemic between January and June 2021. It also waives certain administrative and environmental requirements to expedite this process.

Ordinance authorizing the City Administrator to amend certain leases and forgive rent due between January 2021 and June 2021 with nonresidential tenants, and waiving Administrative Code and Environmental Code requirements enacted after the most recent modification of each lease, in order to allow for expeditious rent forgiveness necessitated by the financial hardship caused by the public health emergency related to the COVID-19 pandemic.

This resolution approves an increase of over $10.6 million to a contract with the San Francisco Public Health Foundation for the Community Health Engagement Program, raising the total contract amount to just over $20 million through the end of 2024. It also allows the Department of Public Health to make minor amendments to the contract as needed without significantly increasing the city's obligations.

Resolution approving Amendment No. 2 to the agreement between the San Francisco Public Health Foundation and the Department of Public Health (DPH) to provide program administration and support services to the Community Health Engagement Program, to increase the contract amount by $10,668,262 for a total amount not to exceed $20,027,567 for a total agreement term of January 1, 2020, through December 31, 2024, to commence following approval by the Board of Supervisors, and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.

This resolution approves an increase of nearly $18.2 million to an existing contract with Helios Healthcare for behavioral health services, raising the total agreement to about $27.9 million and extending its duration until June 30, 2028. It also allows the Department of Public Health to make minor amendments to the contract as needed without significantly increasing the city's obligations.

Resolution retroactively approving Amendment No. 2 to the agreement between Helios Healthcare, LLC and the Department of Public Health (DPH), for behavioral health services, to increase the agreement by $18,239,925 for an amount not to exceed $27,904,325; to extend the term by six years and six months from December 31, 2021, through June 30, 2028, for a total agreement term of July 1, 2018, through June 30, 2028; and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.

This resolution approves an increase of $2,085,454 to an existing contract with Health Advocates, LLC for services related to recovering funds for uncompensated care, raising the total contract amount to $20,100,000 and extending the contract term by two years. It also allows the Department of Public Health to make minor amendments to the contract without increasing the city's obligations.

Resolution retroactively approving Amendment No. 2 to the agreement between Health Advocates, LLC and the Department of Public Health (DPH) for uncompensated care reimbursement recovery services, to increase the agreement amount by $2,085,454 for an amount not to exceed $20,100,000; and to extend the term by two years from December 31, 2021, through December 31, 2023, for a total agreement term of January 1, 2014, through December 31, 2023; and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.

This legislation calls for a hearing to discuss the housing needs of San Francisco's growing senior population and how the city plans to address these needs. It also requests reports from various city departments on their strategies for providing housing for seniors.

Hearing on the continuum of housing needs of the growing senior population and the City’s strategies to comprehensively plan for and provide this housing across the spectrum; and requesting that the Department of Disability and Aging Services, Planning Department, Mayor’s Office of Housing and Community Development, Department of Homelessness and Supportive Housing, and Department of Public Health to report.

This ordinance requires hospitals and skilled nursing facilities in San Francisco to report annually to the Department of Public Health on the number and demographics of patients transferred out of the City for skilled nursing care, as well as those who qualify for such care but remain in the City. The goal is to gather data on patient transfers to improve health care services.

Ordinance amending the Health Code to require general acute care hospitals and hospital-based skilled nursing facilities in the City to report annually to the Department of Public Health the number of, and certain demographic information regarding, patients transferred to a health facility outside of the City to receive skilled nursing care and patients who qualify for skilled nursing care but are not transferred to a health facility outside of the City.

This ordinance extends the restrictions on residential evictions in San Francisco, allowing them only for non-payment of rent, violence, or health and safety issues until December 31, 2021. It amends the Administrative Code to reflect this change.

Ordinance amending the Administrative Code to extend the COVID-19 based limit on residential evictions, which allows evictions only if based on the non-payment of rent or violence or health and safety issues, from September 30, 2021, through December 31, 2021.

This resolution allows the Department of Public Health to use a $6 million grant for a mental health program aimed at supporting student services from October 1, 2021, to September 30, 2025. It has been officially approved and is now in effect.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant in the amount of $6,000,000 from the Mental Health Services Oversight and Accountability Commission for participation in a program, entitled “Mental Health Student Services Act of 2019,” for the period of October 1, 2021, through September 30, 2025.

This legislation calls for a hearing to review the implementation of Mental Health SF, focusing on the hiring process and status of funded positions from the 2020-2021 and 2021-2022 budgets. It requests reports from the Department of Human Resources and the Department of Public Health on these matters.

Hearing on the report of the implementation of Mental Health SF, including positions funded in the Fiscal Years (FYs) 2020-2021 and 2021-2022 budgets, when the hiring process started for each position, when each position was actually filled, and how many positions continue to be vacant; and requesting the Department of Human Resources and Department of Public Health to report.

This resolution allows the Department of Public Health to use a $3 million grant for a program focused on coordinating care and managing transitions for individuals with substance abuse and mental health issues. The funding is retroactively authorized for the period from September 30, 2021, to September 29, 2023.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant in the amount of $3,000,000 from the Substance Abuse and Mental Health Services Administration for participation in a program, entitled “The Care Coordination and Transitions Management Project,” for the period of September 30, 2021, through September 29, 2023.

This resolution extends the contract with Heluna Health for the San Francisco Homeless Outreach Team by 19 months and increases the total funding by $12,685,125, bringing the total contract amount to $51,819,067. It aims to continue providing outreach and case management services for people experiencing homelessness in the city.

Resolution approving the seventh amendment to the contract between the City and County of San Francisco and Heluna Health to provide comprehensive outreach and case management programming to meet the needs of people experiencing homelessness in San Francisco, known as the San Francisco Homeless Outreach Team, to extend the contract agreement term for 19 months from November 30, 2021, for a total term of August 1, 2014, through June 30, 2023, and increasing the contract amount by $12,685,125 for a total contract amount not to exceed $51,819,067.

This ordinance extends various deadlines related to Medical Cannabis Dispensaries and Cannabis Retail Use in San Francisco, pushing them from 2021 to 2022 and 2023. It also allows for the extension of Temporary Cannabis Business Permits and the Cannabis Event Permit pilot program.

Ordinance amending the Health Code, Planning Code, and Police Code to extend the sunset date for provisions governing Medical Cannabis Dispensaries from December 31, 2021, to December 31, 2022; to extend the sunset date for allowing the conversion of Medical Cannabis Dispensaries with Planning Commission approval to a Cannabis Retail Use from January 1, 2022, to January 1, 2023; to allow the extension of Temporary Cannabis Business Permits for additional 120-day terms through December 31, 2022, rather than December 31, 2021; and to allow the extension of the Cannabis Event Permit pilot program through December 31, 2023, rather than December 31, 2021; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1.

This resolution extends the grant agreement with the San Francisco-Marin Food Bank for the COVID-19 Food Assistance Program by six months and increases the total funding by approximately $7.4 million. The new grant term will run from July 1, 2020, to June 30, 2022, starting on October 15, 2021.

Resolution approving a second amendment to the grant agreement between the City and County of San Francisco and San Francisco-Marin Food Bank, for the administration of the COVID-19 Food Assistance Program, to extend the grant term by six months for a total term of July 1, 2020, through June 30, 2022, and to increase the grant amount by $7,424,820 for a total not to exceed amount of $22,951,645 to commence on October 15, 2021.

This resolution allows the Department of Public Health to accept and use a donation of software licenses for an ophthalmology application valued at nearly $60,000, which will support eye care services until June 2025. The donation comes from the San Francisco General Hospital Foundation.

Resolution retroactively authorizing the Department of Public Health to accept and expend an in-kind gift of perpetual software licenses of the ZEISS forum ophthalmology application valued in the amount of $59,949 from the San Francisco General Hospital Foundation for the Department of Public Health to provide eye care and eye disease management for the project period of July 8, 2016, through June 16, 2025.

This resolution supports Mayor London N. Breed in declaring a local emergency due to the overdose crisis and calls for the immediate establishment of overdose prevention sites. It aims to address the rising number of overdose incidents in the city.

Resolution urging and supporting Mayor London N. Breed in proclaiming a declaration of the existence of a local emergency around the overdose crisis and immediately implementing overdose prevention sites.

This resolution officially designates October 2021 as "Children’s Environmental Health Month" in San Francisco to raise awareness about environmental issues affecting children's health. It aims to promote initiatives and education focused on improving the environmental conditions for children in the city.

Resolution recognizing October 2021 as “Children’s Environmental Health Month” in the City and County of San Francisco.

This hearing addresses issues with Shared Mobility Device users and companies not following safety laws meant to protect all road users, including vulnerable groups. It requests reports from the Municipal Transportation Agency and the companies involved on their compliance with these regulations.

Hearing to address non-compliance by Shared Mobility Device permittees and riders of Shared Mobility Devices with laws and regulations designed to protect the health and safety of riders and pedestrians, including families, seniors and people with disabilities; and requesting the Municipal Transportation Agency and Shared Mobility Device permittees to report.

This resolution urges President Biden to halt the distribution of COVID vaccine boosters to the general public and to advocate for a waiver on intellectual property rights related to vaccines, while also promoting technology transfer to help low-to-middle income countries. The goal is to support global efforts to end the pandemic.

Resolution urging President Joe Biden to pause distribution of COVID vaccine boosters to the general population and to take a leadership role in supporting the Trade-Related Intellectual Property Rights (TRIPS) waiver while promoting technology information transfer as it relates to vaccinations to low-to-middle income countries in order to end this global pandemic.

The legislation involves a public hearing to discuss proposed ordinances related to a partial settlement of lawsuits against major opioid distributors and manufacturers, seeking abatement funds totaling between $33 million and $61 million over several years. This hearing is scheduled for November 2, 2021, at 3:00 p.m.

Hearing of the Board of Supervisors sitting as a Committee of the Whole on November 2, 2021, at 3:00 p.m., to hold a public hearing to consider the proposed Ordinances (File Nos. 211071 and 211072) regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.

This legislation allows the San Francisco Board of Supervisors to hold a closed session to discuss legal advice regarding ongoing lawsuits against major opioid distributors and manufacturers, seeking settlement funds for the city. The lawsuits aim to secure between $27 million to $50 million and $6 million to $11 million in abatement funds to address the opioid crisis over specified timeframes.

Closed Session for the Board of Supervisors to convene on November 2, 2021, pursuant to California Government Code, Section 54956.9, and San Francisco Administrative Code, Section 67.10(d)(1), for the purpose of conferring with, or receiving advice from the City Attorney regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211071); and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211072); scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.

This resolution approves an increase of $3,689,230 to the existing agreement with the Bayview Hunters Point Foundation for Community Improvement, raising the total to $13,489,343, and extends the contract term by fifteen months. It also allows the Department of Public Health to make minor amendments to the contract as needed without significantly increasing the city's obligations.

Resolution approving Amendment No. 2 to the agreement between Bayview Hunters Point Foundation for Community Improvement and the Department of Public Health (DPH) for behavioral health services, to increase the agreement by $3,689,230 for an amount not to exceed $13,489,343; and to extend the term by fifteen months from March 31, 2022, to June 30, 2023, for a total agreement term of July 1, 2018, through June 30, 2023; and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.